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Damaged DNA leads to genomic instability that causes many diseases such as cancer. Cells evolved
the DNA damage response (DDR), which recognizes and efﬁciently repairs damaged DNA through
the action of highly coordinated signalling mechanisms. Recently, a non-degradation-linked
Lys(K)63-ubiquitin signal emerged as a signalling pathway essential for orchestration of the DDR
after DNA double strand breaks (DSBs). How the ubiquitin-dependent proteasomal degradation sys-
tem (UPS) coordinates DDR after DSBs is still poorly understood. Here, we review the evidence, sug-
gesting the involvement of the degradation-linked K48-ubiquitin signal and the proteasome at the
sites of DSBs. Based on this we propose the UPS as a central element in the orchestration of the DDR
at the sites of DSBs. The suggested model is also discussed in the context of anti-cancer therapy.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The genome is constantly challenged by various endogenous
and exogenous factors such as oxygen species produced during
daily metabolic processes or exposure to sunlight, cigarette smoke,
some medical treatments and many others. All these factors attack
DNA directly or indirectly, causing different alterations such as oxi-
dations, depurinations or depyrimidations, nicks, gaps or even DNA
double strand breaks (DSBs). DSBs are the most deleterious lesions,
which can, if left unrepaired, cause chromosome rearrangements
and chromosomal loss that ﬁnally leads to genomic instability
and cancer. Therefore, the efﬁciency of DSB repair mechanism is
important for genome preservation and cell survival. Irrespective
of the type of DNA lesion, damaged DNA is rapidly detected and
activates a highly coordinated signalling pathway known as the
DNA damage response (DDR). Consequently, DDR controls the
recruitment of different repair proteins, the activation of DNA
checkpoints that arrest cell cycle progression, transcriptional re-
sponse or even activates apoptosis when DNA is severely damaged.
The main coordinators of DDR are different posttranslational mod-
iﬁcations taking place on the components of the DDR, such as
phosphorylation, ubiquitination, acetylation and others. Protein
phosphorylation is the ﬁrst and a very well understood signal in
the orchestration of DDR [1,2]. A recent EMBO workshop on theal Societies. Published by Elsevier
h (K. Ramadan).interference between the ubiquitin family and the DNA damage re-
sponse (Croatia, September 2010) highlighted ubiquitination as an
emerging hot topic in the DDR with many unresolved questions
[3]. Currently, the research in the ﬁeld of DDR is mostly focused
on the understanding how are different DDR proteins recruited
to the sites of DNA lesions in ubiquitin dependent manner, orga-
nized by histone monoubiquitination and K63-polyubiquitination
[4]. Upon the assembly of the DDR proteins at the sites of DSBs
and the completion of precisely coordinated steps in the DDR path-
way, these proteins also have to be disassembled and removed.
This suggests that the disassembly, removal and/or degradation
of chromatin associated DDR proteins is an integral mechanism
in the DSB repair and post-repair processes. As the protein re-
moval, disassembly and degradation of the damaged and short
lived proteins from different cellular locations are mostly coordi-
nated by the ubiquitin-proteasome system (UPS), we review here
the evidences for the presence and the role of K48-ubiquitin signal
and proteasome at the sites of DSBs.
2. The ubiquitin-proteasome system (UPS)
The UPS machinery is composed of ubiquitin, proteasome and a
multitude of enzymes catalyzing the ubiquitination reaction on a
variety of substrates, leading to the ﬁnal degradation of polyubiqui-
tinatedproteins and the release of free ubiquitin. TheUPS is virtually
involved in any cellular process, which depends on degradation
and regulation of intracellular proteins [5]. Ubiquitin is a highlyB.V. Open access under CC BY-NC-ND license.
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when attached to proteins in a highly conserved manner. An enzy-
matic cascade mediates the process of ubiquitination, starting with
an E1 ubiquitin-activating enzyme, which transfers the ubiquitin to
the E2 ubiquitin-conjugating enzyme. The ﬁnal step of ubiquitina-
tion, in which the ubiquitin is translocated to the target protein, is
catalyzed by a substrate speciﬁc E3 ubiquitin ligase. There are seven
lysine (K) residues in the ubiquitinmolecule (K6, K11, K27, K29, K33,
K48, K63), which allow the diversity of the ubiquitin signal on the
target protein [6]. Different varieties of ubiquitin structures on la-
beled proteins regulate protein degradation, protein–protein inter-
action or protein’s enzymatic activity. The basis of the ubiquitin
signal complexity is the fact that human genome encodes only two
E1 Ub-activating enzymes, at least thirty-eight E2 Ub-conjugating
enzymes and 600–1000 E3 Ub-ligases [7,8]. It is generally consid-
ered that K48-linked polyubiquitination targets its substrates to
the proteasome, for subsequent degradation, while K63-linked
polyubiquitination is important for targeting substrates to different
cellular locations or DNA repair. In these processes ubiquitin acts as
a signaling component,which triggersmolecular events. Once a pro-
tein is ubiquitinated, it can be recognized and processed via a di-
verse set of ubiquitin receptors, containing ubiquitin-binding
domains (UBDs). UBDs are diverse modules in a protein that can
bind and distinguish different types of ubiquitin modiﬁcations
[7,9]. This non-covalent and speciﬁc binding of different lengths of
ubiquitin chain further contributes to the speciﬁcity and complexity
of the ubiqutin signaling in the cell. The proteasome is a 2.5 megad-
alton protease, existing in multiple forms. The major proteasome
assembly is a 26S proteasome, composed of the 19S regulatory par-
ticle and the 20S core particle with protease activity. Proteins
marked with K48-linked polyubiquitination dock onto a diverse
set of ubiquitin receptors of the 19S regulatory particle of the pro-
teasome to be, in turn, translocated into an internal chamber,within
the 20S proteolytic core particle, where they are hydrolyzed [10].
Ubiquitination is a reversible process and ubiquitin is eventually re-
moved from its substrates by the action of a speciﬁc class of prote-
ases, called the de-ubiquitinating enzymes (DUBs). In the process
of proteasomal degradation the activities of DUBs are to spare ubiq-
uitin (ubiquitin recycling), to spare someproteins fromdegradation,
to re-localize protein to its site of origin or to abolish some protein–
protein interactions [11]. Nearly 100 putative DUBs are encoded by
the human genome. In their structure the DUBs also contain a vari-
ety of UBDs, thus displaying speciﬁcity for different ubiquitin chains
[12].3. DNA damage response after DNA double strand breaks
DNA double strand breaks present a serious risk to cells, as the
failure of their repairment results in chromosomal rearrangement
or cell death. DSBs can be generated endogenously during numer-
ous processes: when DNA replication forks approach blocking DNA
lesions that leads to a fork collapse, V(D)J recombination, class
switch recombination, meiosis or even mitosis, when dicentric or
catenated chromosomes are pulled to the opposite poles. DSBs
can also be generated by exogenous sources such as ionizing radi-
ation (IR), chemical agents or UV light [13]. In mammals DSBs are
repaired by two main mechanisms, homologous recombination
(HR) and non-homologous end-joining (NHEJ). The process of HR,
which requires a signiﬁcant length of sequence homology that
could be found in either sister chromatid or in the homologous
chromosome and can therefore occur only in the late S or G2 phase
of the cell cycle, is considered to be error-free. NHEJ process uses
little or no sequence homology to repair DSBs and thus occurs
throughout the cell cycle. As NHEJ repairs DSBs regardless of the
DNA sequence, it is usually error-prone [14]. In contrary to yeast,where HR is the main DSB repair pathway, NHEJ is a major mam-
malian DSB repair mechanism [15,16]. Accordingly, the majority of
exogenously induced and accidental DSBs, with the exception of
those arising after DNA replication collapse, are repaired by the
NHEJ. One of the reasons for this is the extensive chromosome
condensation that makes homology search extremely difﬁcult in
the G2 phase, as well as in the G1 phase of the cell cycle. NHEJ
is also responsible for the repair of DSBs produced during V(D)J
recombination and class switch recombination [15]. In general,
the defects in NHEJ increase the radiation sensitivity, immune
deﬁciency and lead to hematological malignancy, particularly to
different kinds of lymphomas, whereas the defects in HR contrib-
ute to a variety of human cancers, but mostly breast and ovarian
cancers [17].
In higher eukaryotes DSBs initiate the phosphorylation of his-
tone H2A variant H2AX at serine 139, generating gamma-H2AX
(c-H2AX). In response to DSBs, c-H2AX is phosphorylated by
PI(3)K-like kinases: ATM (ataxia telangiectasia mutated protein),
ATR (ATM and Rad3 related protein) or DNA-PK (DNA-dependent
protein kinase). The formation of c-H2AX foci is the earliest event
in the activation of DNA damage checkpoint pathways in response
to DSBs and it is considered to be the main marker of DSBs [18].
One of the ﬁrst proteins, accumulating at the site of DSB in eukary-
otic cells, is the heterotrimeric protein complex MRE11-RAD50-
NBS1 (MRN). This conserved and essential factor functions in a
multitude of cellular processes involving DSBs (DNA replication,
meiotic recombination and apoptosis) [19]. The resulting DNA
damage checkpoint not only arrests cell cycle progression until
DNA damage is repaired, but also activates and regulates the
DNA repair machinery. Together, these events comprise the so-
called DDR [20]. In the last decade, much progress has been done
in understanding the DDR and its cascades. It became clear that
DDR is a tightly organized mechanism, governed by regulated pro-
tein–protein interactions and controlled by posttranslational mod-
iﬁcations, especially phosphorylation. In the last few years, it came
to light that, in addition to phosphorylation, DDR is also controlled
by ubiquitination and sumoylation [21–24].
3.1. The role of non-degradation-linked K63-ubiquitin signal and sumo
system in the assembly of DSB repair proteins
The ubiquitin pathway regulates many steps in DNA repair:
stalled DNA replication forks [25], translesion DNA synthesis
[26], base excision repair [27], nucleotide excision repair [28].
Moreover, a tremendous progress has been achieved in the last
few years in understanding the new link between regulatory ubiq-
uitin function and DSB repair [4,21,22,29–33]. These reports iden-
tiﬁed K63-ubiquitin chain on histones in the vicinity of DSBs, as an
essential signal for the orchestration of the DDR. The phosphory-
lated mediator of a DNA damage checkpoint 1 (MDC1) serves as
a loading platform for RNF8 E3 ubiquitin ligase. RNF8 catalyzes
the local histone ubiquitination and thereby renders the DSB-
ﬂanking chromatin permissive for the assembly of the additional
factors such as 53BP1 and BRCA1 [31,34]. Even though RNF8 is nec-
essary to trigger the DSB-associated ubiquitination, it is not sufﬁ-
cient to sustain protein ubiquitination on damaged DNA. RNF168,
another ubiquitin E3 ligase, is recruited in a RNF8 dependent man-
ner at the sites of DSBs, thus amplifying the ubiquitin signal for the
accumulation of repair proteins [35,36]. RNF8 and RNF168 are
chromatin associated RING ﬁnger proteins, which act in concert
with E2 enzyme UBC13 and an adapter protein and E3 ligase
HERC2, to catalyze the formation of K63-ubiquitin conjugates on
histones H2A and H2AX, surrounding the site of DNA damage
[37]. Mutation of the RNF168 gene causes the RIDDLE syndrome
(radiosensitivity, immunodeﬁciency, dysmorphic features and learn-
ing difﬁculties), a human immunodeﬁciency disorder associated
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ubiqutin ligases at DSBs is BRCA1, but its substrates and role in the
DDR still remain unclear [23,24,35]. Loss of BRCA1 ligase activity,
due to the mutations in its RING domain, is associated with predis-
position to breast cancer [39]. In addition, Rad18, a well-understood
E3 ligase for PCNA monoubiquitination at stalled replication fork
was shown to play an important role in HR and DDR [40,41].
Rad18 recruitment to DSBs occurs downstream of the K63-ubiqui-
tin signal, created by RNF8 and RNF168, and its recruitment does
not depend on BRCA1. Even though Rad18 is E3 ubiquitin ligase,
its ligase activity is not required for the HR, but rather its physical
presence at the sites of DSBs [41]. A further complexity of this cascade
was elucidated just a year ago [23,24], when two independent
groups showed that E3 sumo ligases regulate the orchestration of
DNA repair at DSBs. They showed that two E3 sumo ligases, PIAS1
and PIAS4, are required for the effective ubiquitin chain formation
mediated by RNF8, RNF168 and BRCA1.
3.2. The role of proteasome at the sites of DSBs
The role of a canonical, non-degradation-linked K63-ubiquitin
signal is well understood in the orchestration of DDR after DSBs
(see Section 3.1). The understanding of the UPS, composed of
K48-polyubuiquitinated substrates and proteasome, is obscured
at the sites of DSBs. Protein degradation by the proteasome is vir-
tually involved in any cellular process; therefore its involvement in
the degradation of chromatin bound proteins would not be surpris-
ing. A large molecular machinery of the proteasome is localized in
both, the cytoplasm and the nucleus of mammalian cells. Nuclear
proteasome is enzymatically active and mostly localized in euchro-
matin, at the periphery of heterochromatin and nucleoli [42,43]. Its
intrinsic proteolytic nuclear activity suggests that it is assembled
as a full 26S complex in the nucleus [44]. Although the majority
of the ubiquitinated substrates are located in the nucleus and chro-
matin represents one of the largest protein assemblies in the cell,
the function of proteasomal degradation in chromatin metabolism
and even more in DSB repair is poorly understood [45]. Although
major DNA repair mechanisms are known to be regulated by ubiq-
uitination in some way, the proteasomal degradation of DNA repair
proteins was mostly investigated in nucleotide excision repair and
base excision repair [21,27,46]. Surprisingly, even though K63-
ubiqutin signal is essential for DSB repair, the role of the protea-
some and K48-ubiquitin signal at the sites of DSBs did not attract
a lot of attention in the ﬁeld so far. Genetic, biochemical and
cell-biological data strongly suggest a physical presence of the pro-
teasome and its regulatory factors at the sites of DSBs in both, yeast
and human. Genetic screen of temperature sensitive yeast mutants
for chromosomal instability (CIN) showed that a defect in the nu-
clear localization of the proteasome subunits represents a major
functional group of genes responsible for CIN [47]. One of the rea-
sons for CIN, caused by the absence of proteasome in the nucleus,
was impaired DNA repair due to the retention of Mms22, a part of
SCF-Rtt101-based ubiquitin ligase complex, on chromatin. The
retention of Mms22 at the sites of DSBs prevents disassembly of
Mre11 and recruitment of downstream signaling pathways, such
as recruitment of Ddc2 (human ortholog ATRIP) and Rad52 [47].
In other study, the chromatin immunoprecipitation analysis
showed a recruitment of proteasome subunits, 19S and 20S, to
DSBs in yeast. Moreover, this recruitment is dependent on Rad52
and DNA polymerase IV, the components of both HR and NHEJ re-
pair [48]. There is also evidence for physical presence of the protea-
some at the sites of DSBs in mammalian cells. BRCA2, a protein
important for the loading of Rad51 on the 30single strand DNA
and therefore a crucial factor in the HR repair, associates with
RPN3 and RPN7, subunits of 19S proteasome. Whereas the associ-
ation between BRCA2 and RPN3 is intermediated by DSS1 (Sem1 inyeast), a non-essential 19S subunit, its association with RPN7 is di-
rect. Most important, while measuring HR the authors found that
the inhibition of the proteasome function shifts the process of re-
pair from error-free gene conversion to more error-prone single-
strand annealing repair in mammalian cells [49]. These results
indicate the physical association of the proteasome with the sites
of DSBs and also its function in the selection of DSB repair pathway
in yeast. There is also evidence that MG132 (proteasome inhibitor)
treatment of human cells suppresses the HR pathway and the
recruitment of RPA, Rad51, BRCA1 and ATR at the sites of DSBs,
but does not signiﬁcantly affect NHEJ pathway [50]. Besides prote-
asomal physical and functional involvement at the sites of DSBs in
eukaryotes, the proteasome activator (PA200) and regulator (Rpn4)
are taking part at the sites of DSBs too. PA200 is recruited to dam-
aged chromatin after IR and forms distinct nuclear foci in mamma-
lian cells [51]. PA200 associates with both, 19S and 20S, and is
recruited on chromatin at the late time point after IR. Increased
levels of proteasome subunits on chromatin, during the recovery
time after IR, correlate with increased levels of the proteasome
tryptic and post-glutamyl activity [52]. Even though the depletion
of PA200 causes hypersensitivity to IR, DSB repair pathways such
as HR and NHEJ are not affected, suggesting rather its indirect role
in the preservation of genome stability. As the recruitment of 19S
and 20S proteasome on damaged chromatin is not dependent on
PA200 and PA200 only controls post-glutamyl proteasome activity,
it might rather be that different proteasome subcomplexes have
distinct functions during the kinetics of DNA repair.
The expression of proteasome subunits is regulated by a nega-
tive feedback loop in eukaryotes, including humans [53]. Rpn4 is
a yeast protein important for this regulation [54], but the human
homologue has not been identiﬁed yet. Rpn4 is a substrate, ligand
and a transcriptional regulator of the 26S proteasome and its sta-
bilization leads to an increased expression of the proteasome sub-
units. At the same time, Rpn4 stabilization down-regulates several
key NHEJ proteins. Except its negative effect on expression of NHEJ
genes, Rpn4 directly binds to DSB and prevents the recruitment of
Ku80, a key factor in HNEJ. Associated delay in the dissociation of a
non-degradable Rpn4 and proteasome from the site of DSB sug-
gests a direct involvement of the proteasome dependent degrada-
tion at the sites of DSBs [55]. Finally, physical localization of
proteasome subunits at the sites of DSBs was recently identiﬁed by
chromatin immunoprecipitation method in human cells (L. Butler
and J. Morris, personal communication). The evidences presented
here clearly indicate the proteasome as a constitutive and conserved
part of the DSB repair machinery, from yeast to human.
3.3. Degradation-linked K48-ubiquitin signal at sites of DSBs
DSBs induce rapid polyubiquitination of DDR proteins such as
53BP1, Mdc1, TopBP1, Nbs1, ATRIP and Claspin, which is most
probably mediated by K-48 ubiquitin chain. The proteasomal deg-
radation of these proteins is however stabilized by USP28, a
deubiquitinating enzyme associated with 53BP1 [56]. In addition,
current literature describes the proteasome in a physical and func-
tional association with DSB and its involvement in the regulation of
DDR (see Section 3.2). Nevertheless, the main function of the pro-
teasome, namely the degradation of K48-polyubiquitinated sub-
strates at the sites of DSBs, is not well understood. To our
knowledge the ﬁrst systematic analysis in resolving this issue
was done by the Funabiki laboratory, using the biochemical
advantage of the Xenopus egg extract system coupled to mass
spectrometry approach [57]. It was shown that the majority of
polyubiquitinated proteins at DSBs are K48-ubiquitin linked, while
some were K63-ubiquitin linked. No other ubiquitin chain isoforms
were observed. One of the K48-ubiqutinated substrates at the sites
of DSBs was Ku80, a central element of NHEJ pathway. Beside this
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ponent of SCF E3 ubiquitin ligase complex, Cul1 was detected as
well. Cul1 recruitment to the sites of DSBs was completely depen-
dent on Ku80, suggesting Ku80 as its main substrate. Interestingly,
although the proteasome degrades K48-polyubiquitinated Ku80
once it is released from the DSBs, the proteasomal activity is not
required for the actual removal of Ku80 from DSBs. This suggests
that K48-polyubiquitinated Ku80 is released from the DSBs by
some other factor, which can recognize and extract K48-polyubiq-
uitinated proteins from chromatin and thus present them to pro-
teasome for consecutive degradation. A similar case was
described for the removal of Aurora B protein from chromatin by
an ubiquitin-dependent chaperon p97/Cdc48 at the end of mitosis
[58]. Therefore, a K48-ubiquitin mediated, but proteasomal inde-
pendent removal of proteins may be a general mechanism for pro-
tein disassembly from DNA. Whether K48-polyubquitinated Ku80
is indeed removed by p97/Cdc48 from DSBs still remains to be dis-
covered. Even though Ku80 dissociates from DSBs, its removal is
not required for the completion of NHEJ [57].
Proteasomal dependent degradation of MDC1, a key component
of DDR after DSB repair, at the site of DSBs plays an important
role for efﬁcient DSB repair [59]. MDC1 associates with chromatin
under physiological conditions, but after induction of DSBs by IR,
it becomes heavily K48-polyubiquitinated and degraded. The
inhibition of proteasome causes retention of MDC1 at DSB sites,
as analyzed by immunoﬂuorescent microscopy and chromatin
immunoprecipitation. Consequently, MDC1-accumulation inhibits
the recruitment of BRCA1 at the sites of DSBs, in RNF8 independent
manner. The kinetics of MDC1 foci removal from the sites of DSBs,
was strongly delayed in proteasome-inhibited cells, but the kinet-
ics of c-H2AX foci recovery was nearly identical under both, pro-
teasome treated and non-treated conditions. This additionally
suggests that MDC1 retention at the sites of DSBs is indeed due
to the proteasome degradation effect and is not an indirect effect
of delayed DNA repair. In conclusion, MDC1, as an early factor in
DDR cascade, must be degraded in a proteasome dependent man-
ner to allow the recruitment of downstream factors, at least BRCA1,
at sites of DSBs.
E3 ubiquitin ligase BRCA1 is the crucial protein in the HR repair
process, whose mutations are associated with the development of
some types of breast, ovarian and prostate cancer. It is important to
note that BRCA1 functions as an E3 ubiquitin ligase only when in
heterodimeric complex with BARD1. While screening for proteins
that mediate BRCA1 protein degradation a group of authors discov-
ered that HERC2 is an E3 ubiquitin ligase which polyubiquitinates
BARD1-uncoupled BRCA1 and targets it for proteasomal degrada-
tion. HERC2 physically interacts with BRCA1 and promotes its deg-
radation during S-phase of the cell cycle. This interaction rapidly
declines when cells enter G2/M phase of the cell cycle when BRCA1
is in the complex with BARD1 and thus protected from HERC2
interaction and degradation. This regulation might have a direct ef-
fect on the pathogenesis, diagnosis and prognosis of primary breast
cancers, as a half of the 60 tested breast cancers express HERC2.
This expression was negatively correlated with BRCA1 expression
in some cases [60]. Similarly, BRCA1 is polyubiquitinated and de-
graded in a proteasome dependent manner rapidly after IR, in
the S and G2/M phase of the cell cycle [61].
CtIP, a protein required for the initiation of end resection in HR
and microhomology mediated end-joining pathways (specialized
end-joining pathway), is polyubiquitinated by E3 ubiquitin ligases
SIAH-1 and BRCA1. While the function of BRCA1 E3 ligase, in the
formation of K6-ubiquitin chain on CtIP and its consequent recruit-
ment to the damaged chromatin, is well investigated, the effect of
SIAH-1 on CtIP polyubiquitination and its proteasome dependent
degradation is not clear [62,63]. There are also examples of the
importance of UPS in the repair of collapsed DNA replication forks.Due to different topological DNA structures, DNA lesions or DNA-
protein complexes DNA replication machinery collapses, which
leads to the formation of DSBs. Such DNA damage represents a
manageable substrate for the efﬁcient restart of DNA replication
and thus preventions of genome instability [64]. Replication re-
lated DSBs are repaired by DSB repair mechanisms, mostly by HR
pathway, but to some extend also by NHEJ pathway [65,66]. A re-
cent discovery of a novel regulator of DSB repair after replication
stress, Mms22 in yeast and its ortholog Mms22L in human, speaks
in favor of the important role of K48-ubiquitin signal and protea-
some dependent degradation at the sites of DSBs. Unlike yeast
Mms22, which is a part of SCF-like complex with Rtt101-based
ubiquitin ligase (Cul4 like cullin), the mammalianMms22L is form-
ing a complex with the scaffold-like protein Nfkbil2/TONSL that
has PB1 domain, a type of ubiquitin-like domain known to bind
26S proteasome. Replication related genotoxic stress induces
Mms22 degradation on chromatin, in Cul4 and proteasome depen-
dent manner. The removal of Mms22 from the sites of DSBs allows
the efﬁcient recruitment of downstream factors such as Rad52 and
ATRIP (Ddc2) in yeast, and Rad51 in human (see Section 3.2)
[47,67–70]. These results indicate Mms22 as a negative regulator
of DSBs formation and demonstrate its proteasome dependent deg-
radation as a necessary step for the orchestration of downstream
factors and efﬁcient HR repair. Another E3 ubiquitin ligase, Cul3,
is also involved in the resolution of stalled replication forks in-
duced by camptothecin (CPT), a topoisomerase I inhibitor, in a pro-
teasome dependent manner as well. Stalled topoisomerase I must
be removed from the DNA complex to allow efﬁcient replication
restart by HR pathway. Cul3 polyubiquitinates stalled topoisomer-
ase I, which is consequently degraded by the proteasome [71].
The similar mechanism of protein removal from the damaged
DNA is described for stalled RNA polymerase II complex on UV le-
sion, which is ﬁrstly monoubiquitinated by Rsp (human homo-
logue NEDD4) and then K48 polyubiquitinated by the second in
the sequence of E3 ligases, Elc1/Cul3 [72]. This signals for the pro-
teasome recruitment at the sites of DNA damage. Indeed, RNA pol II
and proteasome physically and functionally interact at the sites of
DNA damage and RNA pol II is degraded in a proteasome depen-
dent manner [73,74].
Finally, the switch between HR and NHEJ is regulated by the
anaphase-promoting complex/cyclosome (APC/C), a large multi-
subunit E3 ubiquitin ligase responsible for the ubiquitination and
consequently proteasomal degradation of cell cycle proteins in
mitosis and G1 phase of the cell cycle. APC/C polyubiqutinatates
Rhp54 in G1 phase. Rhp54 is an ortholog of human Rad54 and a
protein important for loading Rad51 on the single strand DNA
and for the initiation of HR. Its degradation prevents the initiation
of HR events in the cell cycle stage when the sister chromatid is not
available [75]. Proteins recruited to the sites of DSBs and affected
by the UPS are summarized in Table I.4. Targeting the ubiquitin-proteasome pathway and DNA
double strand break repair in anti-cancer therapy
Many proteins that control cellular processes relevant for
tumorigenesis, such as cell-cycle progression, apoptosis, receptor
down-regulation and gene transcription, are regulated by the
UPS dependent degradation. A defect in the proteasome function
was associated with different diseases such as neurodegenerative
disorders, cardiovascular and rheumatoid diseases and cachexia,
but never with cancer, suggesting that cancer cells use the
proteasome for their own purpose [76]. For this reason, the
inhibition of the proteasome function serves as an important
mechanism in anti-cancer therapy. This was demonstrated by the
effect of the boronic-acid derivate bortezomib (Velcade,
Table I
DDR proteins degraded by the UPS at the sites of DSBs.
Protein K48-ubiquitinated/E3-ligase Removal from DSBs/
proteasomal degradation
Consequences of inhibited degradation or removal from
DSBs
Organism References
MDC1 Yes/unidentiﬁed Yes/yes No BRCA1 recruitment Mammals [59]
Ku80 Yes/Cul1 Yes/yes No effect on NHEJ Xenopus
laevis
[57]
BRCA1 Unidentiﬁed/HERC2 and
Unidentiﬁed/unidentiﬁed
Unidentiﬁed/yes
Unidentiﬁed/yes
Increased level of BRCA1 in S-phase. Delayed the onset of
IR induced apoptosis
Mammals [60,61]
CtIP Unidentiﬁed/SIAH-1 Unidentiﬁed/Yes Unidentiﬁed Mammals [63]
Mms22 Unidentiﬁed/Cul4 Yes/yes Mer11 retention, no ATRIP and Rad52 recruitment to
DSBs; no Rad51 recruitment to DSBs
Yeast,
mammals
[47,67–
70]
Topoisomerase
I
Yes/Cul3 Yes/yes No DSBs formation after replication collapse Mammals [71]
53BP1 Unidentiﬁed/unidentiﬁed Unidentiﬁed/yes Unidentiﬁed Mammals [56]
Rad54 Unidentiﬁed/APC-C Unidentiﬁed/yes Sensitivity to DNA damaging agents and suppression of
interhomolog recombinations in mitosis
Yeast [75]
ATRIP Unidentiﬁed/unidentiﬁed Unidentiﬁed/yes Unidentiﬁed Mammals [56]
Nbs1 Unidentiﬁed/unidentiﬁed Unidentiﬁed/yes Unidentiﬁed Mammals [56]
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site in 20S proteasome. Bortezomib is being efﬁciently used in
the therapy of some hematological tumors, such as multiple mye-
loma and refractory mantle cell lymphoma. Even though it has
been known for more than a decade that the inhibition of the
UPS has a role in anti-cancer therapy, the exact molecular mecha-
nism of its action is not completely understood [77,78]. An exten-
sive preclinical research on bortezomib showed the induction of
apoptosis in both, hematological and solid tumors. The reason for
apoptosis might be the balance maintenance between pro- and
ant-apoptotic factors [79]. After the exposure to cellular stressors,
IjB is degraded by the proteasome and NF-jB is released, activat-
ing the transcription of numerous factors involved in cell-cycle
progression, cell adhesion and inhibitors of apoptosis. It is gener-
ally accepted that the inactivation of proteasome suppresses the
degradation of IjB, an inhibitory subunit of a transcriptional acti-
vator NF-jB, thus activating apoptosis [79]. However, the inhibi-
tion of NF-jB activation can not be the sole function of the
proteasome in anti-cancer therapy, because the speciﬁc inhibitor
of IjB, PS-1145, blocks NF-jB inhibition to the same extent as
bortezomib, but has very mild effect on cell proliferation [80].
The DDR has an impact on a wide range of the cellular functions
under physiological conditions such as immune receptor diversity,
production of gametes for sexual reproduction, telomerase homeo-
stasis and aging, as well as on a number of pathological conditions,
such as neurodegenerative diseased, viral infection, genome insta-
bility and cancer [1]. In line with the intact function of the protea-
some in cancer cells, the DSB repair pathway and other DNA repair
pathways are typically not defective in sporadic cancers. The only
exceptions are hereditary cancers where genome stability has been
linked to the mutations in DNA repair genes [81,82]. Targeting of
DNA repair machinery, in particular DSBs repair, by either chemo-
or radiotherapy is being used in anti-cancer therapy since decades.
Plenty of chemical inhibitors that attack DDR pathways at different
levels are widely used for this purpose [83]. We can therefore con-
clude that cancer cells evolved the mechanism to use the UPS, DSB
repair and DDR for their own requirements. This justiﬁes the tack-
ling of UPS and DDR as drug targets in anti-cancer therapy. Down
the line, the inhibition of the proteasomal activity sensitizes differ-
ent tumor cells to DNA damaging agents, such as IR and DNA cross-
linking agents, supporting additionally the importance of these
two pathways in anti-cancer therapy [84]. Despite enormous ef-
forts to achieve the effective anti-cancer chemotherapeutics and
the obvious role of the UPS and DSB repair on the cancer develop-
ment, the direct molecular link between the UPS and DSB repair is
not yet established. Based on the physical and functional involve-
ment of the UPS components at the sites of DSBs, namely the pro-teasome and K48 polyubiquitinated substrates, we want to draw
the attention to the fact that these two pathways directly commu-
nicate. Therefore a combined approach, namely inhibition of the
UPS and DSB repair, might be the strategy of choice for successful
anti-cancer therapy.5. Conclusion
Since the two main E3 ubiquitin ligases, RNF8 and RNF168, and
the deubiquitinating enzyme OTUB1 were discovered, the role of a
non-degradation linked K63-ubiquitin signal at the sites of DSBs is
well established and considered to be the crucial pathway in the
assembly of different DNA repair and signaling factors [85]. On
the contrary, the presence and function of the UPS in the orchestra-
tion of the repair machinery at the sites of DSBs and downstream
signaling pathway is not yet established. The proteins recruited
to the sites of DSBs represent large multi-protein aggregates,
which are visualized by ﬂuorescent microscopy as foci. In order
to preserve the genome stability the UPS must tightly regulate
the removal and/or degradation of these components. There is
plenty of evidence showing that the inhibition of proteasome
activity affects DSB repair (see Sections 3.2 and 3.3). Based on this,
most of the studies concluded that the proteasome and protein
degradation play an important role in DSB repair. The comprehen-
sion of the ubiquitin system in DDR suggests that the inactivation
of proteasome causes depletion of a free pool of ubiquitin in nu-
cleus [35,45]. Therefore, it is not possible to conclude whether
the effect of the UPS on DSB repair machinery is direct or if it is just
a consequence of the depletion of ubiquitin and an inability to gen-
erate canonical K63-ubiquitin signal. However, genetic, biochemi-
cal and cell biological approaches have identiﬁed 26S proteasome
and its regulatory factors as physical and functional components
at the sites of DSBs in yeast and mammalian cells. There is a grow-
ing list of proteins directly involved in DSB repair that are targeted
by K48 polyubiquitination (Table I), a main signal for proteasomal
degradation, at the sites of DSBs. K48 polyubiquitination of the ﬁrst
factors recruited at the sites of DSBs (Mre11, MDC11, Ku80 or
Mms22), their removal and proteasomal degradation strongly sug-
gest the K48-ubiquitin signal as one of the earliest events on the
DSBs. The inability to remove and degrade these factors prevents
further recruitment of down-stream molecules such Rad51, ATRIP
or BRCA1. The proteasome is recruited early after inﬂiction of DSB,
but its proteolytic activity persists for hours (see Sections 3.2 and
3.3). All of the above suggests that proteasomal degradation is
not only involved in post-repair processes, such as to remove the
recruited proteins (aggregates) from repaired lesions, but that it
Fig. 1. The model of degradation mediated by K48-ubiquitin signal and the proteasome at the sites of DSBs: (A) MRN complex, MDC1, RNF8 and Cullins (CRLs) are recruited at
the site of DSB. RNF8 monoubiquitinates histones, which recruit RNF168 to extend the K63-ubiquitin chain. E3 ligases of the Cullin family create K48-ubiquitin chain on early
factors recruited at the site of DSB. (B) Proteasome is recruited on K48-polyubiquitinated substrates at the sites of DSBs. (C) Proteasome degrades early DDR factors at the site
of DSB. This allows the recruitment of late DDR factors such as BRCA1. (D) When DSB is repaired, the proteasome removes residual repair factors.
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the sites of DSBs. The UPS might provide ﬂexibility in remodeling
DNA repair complexes, such as removing/disassembling speciﬁc
proteins from the aggregate, without disturbing the whole com-
plex. We propose the model in which 26S proteasome and K48-
ubiquitin signal are direct and essential elements at the sites of
DSBs, important for the orchestration of DDR (Fig. 1). This model
is also supported by results from our laboratory, as we have de-
tected K48-ubiquitin signal in an early time point after the DNA
damage at the sites of DSBs in human cells (M. Meerang and
K. Ramadan, unpublished data).
Our proposed model aims to contribute to the understanding of
the molecular mechanism of proteasome inhibitors in anti-cancer
therapy. Inhibition of the proteasomal degradation at the sites of
DSBs consequently attenuates DSB repair. As the creation of DSBs
(radiation, camptothecin, etoposide) is used for the therapy of
some cancers, the inhibition of the proteasome activity will di-
rectly affects DSB repair and will have the additive effect in elimi-
nation of the cancer cells (synthetic lethality). The evidences
presented here strongly support two hit-strategy, namely the com-
bination of IR or drugs that cause DSB and bortezomib (proteasome
inhibitor) in anti-cancer therapy.
6. Perspectives
The general mechanism of the canonical ubiquitin signal in
DDR (RNF8/RNF168/K63-ubiquitin chain) is only starting to beinvestigated and understood, and a novel, UPS-linked ubiquitin
signal has already emerged (proteasome/K48-ubiquitin chain).
Next to be discovered are E3-ubiqutin ligase(s), DUBs and other
ubiquitin processing factors involved in K48-ubiquitin chain for-
mation at the sites of DSBs. The exact function of the proteasome
and K48-polyubiquitinated substrates at the sites of DSBs, or even
on chromatin in general, also has to be elucidated. The under-
standing of UPS at the sites of DSBs will hopefully bring us closer
to the challenging issue of designing a successful anti-cancer
therapy.
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